Medicine and Dentistry
Neoplasm
100%
Diseases
96%
Gynecological Oncology
91%
Cervical Cancer
70%
Ovarian Cancer
61%
Uterine Cancer
58%
Radiation Therapy
48%
Cancer
47%
Krukenberg Tumor
46%
Recurrent Disease
40%
Carcinoma
35%
Endometrium Carcinoma
32%
Adenocarcinoma
28%
CA-125
28%
Cervix
28%
Cisplatin
26%
Malignant Neoplasm
26%
Prognostic Factor
25%
Pelvis
24%
Metastatic Carcinoma
23%
Hysterectomy
22%
Surgery
22%
Vulva
22%
Doxorubicin
21%
Gynecology
21%
Obstetrics
20%
Papanicolaou Stain
20%
Paclitaxel
19%
Female Genital Tract Cancer
18%
Uterine Cervix Carcinoma
18%
Phase II Trials
17%
COVID-19
16%
Uterine Cervix Cytology
16%
Oncology
16%
Overall Survival
16%
Laparotomy
15%
Retroperitoneal Lymph Node Dissection
14%
Conservative Treatment
13%
Endometrium
12%
Squamous Cell Carcinoma
12%
Wart Virus
12%
Radical Hysterectomy
11%
Cervical Intraepithelial Neoplasia
11%
Biopsy Technique
11%
Brachytherapy
10%
Social Support
10%
Progression Free Survival
10%
Clinical Significance
10%
Protein P53
10%
Prevalence
9%
Surgeon
9%
Endometrial Hyperplasia
9%
Lymph Node
9%
Rhenium 188
9%
Patient Referral
9%
Bleeding
8%
Exenteration
8%
Magnetic Resonance Imaging
8%
Clinical Trial
8%
Vasculotropin
8%
Cancer Recurrence
7%
Carboplatin
7%
External Beam Radiotherapy
7%
Infection
7%
Cytotechnology
7%
Radioimmunotherapy
7%
Quality of Life
7%
Hyperplasia
7%
Endometrial Cancer
7%
Abdominal Wall
7%
Uterine Cervix
7%
Exploratory Laparotomy
7%
Angioleiomyoma
7%
Health Care Cost
7%
Patient History of Chemotherapy
7%
Treatment Response
7%
Cancer Cell
7%
Papillomavirus Infection
7%
Primary Peritoneal Cancer
7%
Adverse Event
6%
Cancer Therapy
6%
Single Nucleotide Polymorphism
6%
Granulosa Cell Tumour
6%
Human Immunodeficiency Virus
6%
Vulva Carcinoma
6%
Vinblastine
6%
Ovarian Remnant Syndrome
6%
Clomifene Citrate
6%
Interleukin 6
6%
Bevacizumab
6%
Leiomyosarcoma
6%
Mixed Tumor
6%
Mixed Müllerian Tumor
6%
Wound Complication
6%
Bowel Obstruction
6%
Colposcopy
6%
Second Trimester Pregnancy
6%
Fistula
6%
Disease Course
6%
First Trimester Pregnancy
6%
Keyphrases
Cervical Cancer
81%
Tumor
68%
Gynecologic Oncology Group
64%
Group Studies
57%
Ovarian Cancer
48%
Radiation Therapy
45%
Endometrial Cancer
44%
Cisplatin
39%
Chemotherapy
35%
Cervical Carcinoma
34%
Gynecological Cancer
31%
Gynecologic Oncology
29%
Endometrial Carcinoma
27%
During Pregnancy
26%
Phase II Trial
24%
Ovarian Carcinoma
23%
Carbohydrate Antigen 125 (CA125)
22%
Uterus
21%
Recurrent Disease
21%
Paclitaxel
20%
Cervical Cytology
20%
Phase II Study
19%
Prognostic Factors
19%
Obstetrics and Gynaecology
18%
Laparotomy
18%
Cancer Patients
18%
Patient Survival
17%
Gynecologic Malignancies
17%
Cervix
16%
Older Women
16%
Endometrioid Adenocarcinoma
15%
Early-stage Cervical Cancer
15%
Pregnant Women
15%
Brachytherapy
14%
Hysterectomy
14%
Doxorubicin
14%
Primary Peritoneal Cancer
13%
Magnetic Resonance Imaging
13%
Radical Hysterectomy
13%
Pegylated Liposomal Doxorubicin
13%
Malignancy
13%
High-risk Human Papillomavirus (HR-HPV)
12%
Quality of Life
12%
E6 Oncoprotein
12%
Bevacizumab
12%
CA-125 Levels
11%
Carboplatin
11%
Pap Test
11%
Uterine Serous Carcinoma
11%
Invasive Cervical Cancer
11%
Social Support
11%
Disease Progression
11%
Cervical Cancer Prevention
11%
Endometrial Hyperplasia
11%
Risk Factors
10%
Radiotherapy
10%
In Cancer
10%
Metastasis
10%
Oncology Patients
10%
Squamous Cell Carcinoma (SqCC)
10%
Radioimmunotherapy
10%
Atypical Glandular Cells
10%
Ovarian Epithelial Cancer
10%
Hexamethylmelamine
10%
Atypia
10%
Tumor Control
10%
Overall Survival
9%
Endometrial Adenocarcinoma
9%
Local Recurrence
9%
Adjuvant Therapy
9%
Tumor Volume
9%
Vascular Endothelial Growth Factor
9%
Recurrence Rate
9%
Ascites
9%
Adenocarcinoma
9%
Disease-free Survival
9%
Tumor Cells
9%
Epithelial Ovarian Cancer
9%
Gynecologic Surgery
8%
Surgical Treatment
8%
Tumor Size
8%
Recurrent Ovarian Cancer
8%
Uncertain Significance
8%
HPV16
8%
Complete Response
8%
Actuarial Survival
8%
Exploratory Laparotomy
8%
Outcome Prediction
8%
COVID-19 Pandemic
8%
Abdominal Wall
8%
Papanicolaou Smear
8%
Docetaxel
8%
Advanced Ovarian Cancer
8%
Partial Response
8%
Topotecan
8%
Enhancement Pattern
8%
Colposcopy
8%
Atypical Hyperplasia
7%
Disease-free
7%
Vinblastine
7%